Dr. Huang-Ju Tu is an Assistant Professor at Taipei Medical University specializing in translational drug discovery, with a primary focus on neurodegenerative diseases and cancer therapeutics. His research integrates artificial intelligence–assisted drug design, kinase biology, and preclinical validation to accelerate the development of innovative small-molecule therapeutics. Dr. Tu’s work centers on identifying and targeting key signaling kinases with therapeutic applications in Alzheimer’s disease, glioblastoma, and other difficult-to-treat diseases. Beyond scientific discovery, Dr. Tu is committed to building a research environment that fosters independent thinking, interdisciplinary collaboration, and innovation-driven problem solving. He actively mentors students and young researchers to bridge the gap between fundamental research and clinical application.

Our team is dedicated to developing novel small-molecules for the treatment of neurodegenerative diseases and brain tumors. We apply AI-assisted drug discovery strategies to identify compounds with therapeutic potential. We further elucidate the underlying mechanisms through transcriptomic analyses, cellular experiments, and disease animal models. Our ultimate goal is to translate basic scientific discoveries into clinical applications.